Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants …
X Sáez-Llorens, AS Bandyopadhyay, C Gast… - The Lancet, 2021 - thelancet.com
Background Continued emergence and spread of circulating vaccine-derived type 2
polioviruses and vaccine-associated paralytic poliomyelitis from Sabin oral poliovirus …
polioviruses and vaccine-associated paralytic poliomyelitis from Sabin oral poliovirus …
Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial
AS Bandyopadhyay, C Gast, L Rivera… - The Lancet Infectious …, 2021 - thelancet.com
Background Following the global eradication of wild poliovirus, countries using live
attenuated oral poliovirus vaccines will transition to exclusive use of inactivated poliovirus …
attenuated oral poliovirus vaccines will transition to exclusive use of inactivated poliovirus …
Immunogenicity and safety of sabin-strain based inactivated poliovirus vaccine replacing salk-strain based inactivated poliovirus vaccine: An innovative application of …
H Chen, Z Gao, S Bai, X Liu, S Han, Y Xiao, F Liu, Y Yu… - Vaccine, 2021 - Elsevier
Background A domestic Sabin strain-based inactivated poliovirus vaccine (Sabin IPV) was
approved by China Food and Drug Administration in 2017 as a replacement for the Salk …
approved by China Food and Drug Administration in 2017 as a replacement for the Salk …
[HTML][HTML] Post hoc analysis of two clinical trials to compare the immunogenicity and safety of different polio immunization schedules in Chinese infants
T Zhao, Z Mo, Z Ying, T Huang, Y Che, G Li… - Annals of …, 2021 - ncbi.nlm.nih.gov
Background A comparative analysis of the immunogenicity and safety of different poliovirus
immunization schedules in Chinese infants is imperative to guide the administration of …
immunization schedules in Chinese infants is imperative to guide the administration of …
Adverse events following immunization with bivalent oral poliovirus vaccine in Jiangsu, China
J Gao, G Kang, R Hu, L Zhang, J Yu… - British journal of …, 2021 - Wiley Online Library
Aims The bivalent oral poliovirus vaccine (bOPV; Sabin types 1 and 3) replaced the trivalent
OPV (Sabin types 1, 2 and 3) globally in April 2016. A routine schedule of 1 dose of …
OPV (Sabin types 1, 2 and 3) globally in April 2016. A routine schedule of 1 dose of …
Reduced mucosal immunity to poliovirus after cessation of trivalent oral polio vaccine
T Zhao, J Li, H Shi, H Ye, R Ma, Y Fu, X Liu… - Human Vaccines & …, 2021 - Taylor & Francis
The switch from using only trivalent oral polio vaccine (tOPV) to sequential schedules
combining inactivated poliovirus vaccine (IPV) and bivalent oral polio vaccine (bOPV) for …
combining inactivated poliovirus vaccine (IPV) and bivalent oral polio vaccine (bOPV) for …
Direct detection of polioviruses using a recombinant poliovirus receptor
N Gerloff, M Mandelbaum, H Pang, N Collins, B Brown… - Plos one, 2021 - journals.plos.org
Polioviruses are positive-sense, single-stranded RNA picornaviruses and the principal
cause of poliomyelitis. Global poliovirus surveillance has relied on poliovirus isolation in …
cause of poliomyelitis. Global poliovirus surveillance has relied on poliovirus isolation in …
Immunogenicity of sequential poliovirus vaccination schedules with different strains of poliomyelitis vaccines in Chongqing, China: a cross-sectional survey
J Xu, Q Wang, S Kuang, R Rong, Y Zhang… - Human Vaccines & …, 2021 - Taylor & Francis
ABSTRACT A new vaccination schedule with one dose of inactivated polio vaccine (IPV)
followed by three doses of bivalent oral attenuated live polio vaccine (bOPV) was introduced …
followed by three doses of bivalent oral attenuated live polio vaccine (bOPV) was introduced …
[PDF][PDF] City, Panama 4. Sistema Nacional de Investigación, Senacyt, Panama 5. Cevaxin, Panama City, Panama 6. VaxTrials, Panama City, Panama 7. Fighting …
C Gast, AS Bandyopadhyay, X Sáez-Llorens… - 2021 - scholar.archive.org
Accepted Manuscript Page 1 Accepted Manuscript © The Author(s) 2021. Published by
Oxford University Press for the Infectious Diseases Society of America. This is an Open …
Oxford University Press for the Infectious Diseases Society of America. This is an Open …